March 12, 2018
KEY POINTS Praluent is a cholesterol-lowering monoclonal antibody, significantly reduces the combined risk of cardiovascular problems and related deaths in ...
Access articles & resources worth up to US $4, 000 per month.
Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.
Access articles & resources worth up to $4000.
Telemedicine a Blooming Area, Global Investments to Reach ~1 Billion in 2018: Medgenera Report
Billion Dollars Healthcare Startups (2018)
Pharma Giants Gradually Embracing Digital Healthcare Technologies
Is Novartis Betting High to Give First FDA-Approved Gene Therapy for Spinal Muscular Atrophy?
7 New Ideas to Start a Healthcare Business in India (2018)
Pharma Patents: Can India Reward Incremental Innovation?